144 related articles for article (PubMed ID: 37723069)
1. [Analysis of the predictive value of plateletcrit for the degree of liver fibrosis in patients with chronic HBV infection with ALT less than two times the upper limit of normal].
Wang B; Li Y; Xiao L; Xu HT; Xian JC
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):862-868. PubMed ID: 37723069
[No Abstract] [Full Text] [Related]
2. [The comparison of liver inflammation and fibrosis between chronic HBV and HCV infection].
Wang L; Fan YX; Ding Y; Sheng QJ; Zhang C; Zhao LR; Xia TT; An ZY; Bai H; Shi HY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):419-423. PubMed ID: 28763858
[No Abstract] [Full Text] [Related]
3. Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2020 Jun; 27(6):602-609. PubMed ID: 31981279
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
5. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
6. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
Li Q; Ren X; Lu C; Li W; Huang Y; Chen L
Medicine (Baltimore); 2017 Mar; 96(12):e6336. PubMed ID: 28328813
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
[No Abstract] [Full Text] [Related]
8. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract][Full Text] [Related]
9. [Role of FibroScan in liver fibrosis evaluation in patients with chronic hepatitis B virus infection and related influencing factors].
Xie QX; Xu N; Jiang XP; Zhang YF; Zhang ZH; Li JB; Hu XY; Li X
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):659-664. PubMed ID: 27788721
[No Abstract] [Full Text] [Related]
10. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
11. Shear wave elastography for liver fibrosis in chronic hepatitis B: Adapting the cut-offs to alanine aminotransferase levels improves accuracy.
Zeng J; Zheng J; Jin JY; Mao YJ; Guo HY; Lu MD; Zheng HR; Zheng RQ
Eur Radiol; 2019 Feb; 29(2):857-865. PubMed ID: 30039224
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B].
Wang XH; Liu XQ; Cai DC; Hu P; Li H
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024
[No Abstract] [Full Text] [Related]
13. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
14. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of hepatic pathological inflammation and fibrosis condition and its influencing factors in 721 patients with chronic hepatitis B with normal ALT].
Ning HB; Jin HM; Li K; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):746-751. PubMed ID: 36038345
[No Abstract] [Full Text] [Related]
16. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
Yang Q; Liu DP; Li LP; Gu Y; Zhang MX; Liu Y; Yang K
Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):15-20. PubMed ID: 28297773
[No Abstract] [Full Text] [Related]
17. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
18. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
[TBL] [Abstract][Full Text] [Related]
19. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
